Clinical trial technology isn’t the barrier to interoperability; the economics are. Two industry leaders explain why nothing forces systems to connect.
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
ON-DEMAND WEBINARS
Grant Williamson and Siba Noolu discuss best practices for ensuring quality and speed across EDC platforms for clinical operations, data management, and programming professionals.
With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.
Given the essential role of sleep in overall quality of life and its link to various chronic conditions, accurately measuring sleep is crucial for developing patient-centric therapies and enhancing public health.
Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-835429430 doctors computer]( "Automation, Analytics, AI, And The Future Of Trial Monitoring")
Automation, Analytics, AI, And The Future Of Trial MonitoringMore teams are utilizing AI and automation to recruit and retain more patients. Discover how predictive analytics allow clinical trial teams to make better prognostications about patient behavior.
-
![GettyImages-1173740575 computer research data]( "Deconstructing Central Rating In Clinical Trials")
Deconstructing Central Rating In Clinical TrialsAnalyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this
-
![Guidelines For Selecting A Medical Device Contract Manufacturer]( "Navigating Biases In Clinical Trial Vendor Selection")
Navigating Biases In Clinical Trial Vendor SelectionBiases, often hidden, can distort vendor selection decisions. Recognizing and addressing them across individuals and teams leads to more objective, aligned, and successful clinical trial outcomes.
-
![supply chain checklist pharmaceuticals-GettyImages-1616023386]( "Revolutionizing Trial Supply Management With The Power Of Free Picking")
Revolutionizing Trial Supply Management With The Power Of Free PickingDiscover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
![Emotions-iStock-471812192]( "The Case For Cognitive Assessments In Phase 1 Clinical Trials")
The Case For Cognitive Assessments In Phase 1 Clinical TrialsRegulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.
-
![clinical-regulation-GettyImages-1423366794]( "Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials")
Why The TrialKit Platform License Agreement Changes The Economics Of Clinical TrialsA platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.
-
![GettyImages-1336251027 IT Specialist Using Laptop Computer In Data Center]( "How We Used Intelligent Automation to Transform Vendor Selection")
How We Used Intelligent Automation to Transform Vendor SelectionDiscover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.
-
![Doctor Using Digital Tablet GettyImages-1530254515]( "Addressing The Challenges Of eCOA Licensing")
Addressing The Challenges Of eCOA LicensingHow can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![GettyImages-1363170016 wearables]( "Creating Success With Digital Measures")
Creating Success With Digital MeasuresRecent research from the Tufts Center for the Study of Drug Development (CSDD) illuminated the substantial ROI of digital endpoints in clinical trials. Discover how to transform your trials today.
RECENT NEWSLETTERS
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
